Terminal breast cancer patients denied life-extending drugs
Charity Breast Cancer Now has issued an urgent plea to Health Secretary Wes Streeting, demanding "immediate action" to dismantle current spending restraints.
The organisation is also calling for the NHS spending watchdog, the National Institute for Health and Care Excellence (Nice), to lower its threshold for what it classifies as a "very severe health condition."
Nice's severity modifier, introduced in 2022, is designed to give greater weight to treatments for more severe illnesses, increasing the likelihood of their recommendation for NHS use.
However, Breast Cancer Now argues that the current criteria are too stringent, potentially preventing thousands of women from accessing vital therapies.
According to Nice, the process raises the threshold for what it considers to be a cost-effective treatment, meaning it can give more expensive drugs the green light.
However, a new report from Breast Cancer Now claims the system means women with incurable breast cancer with months to live may be told their condition does not qualify for the most severe rating.
The call comes after it emerged that the life-extending drug Enhertu will not be made available for women with incurable breast cancer on the NHS in England and Wales.
In November, Nice said talks with manufacturers AstraZeneca and Daiichi Sankyo over the price of the medication had broken down for the third time with no agreement.
Claire Rowney, chief executive at Breast Cancer Now, said: 'The terrifying reality is that unless urgent action is taken thousands of women in the UK with incurable secondary breast cancer could be denied access to vital life-extending treatments because of an unfair system.
'We're talking about patients missing out on access to cutting-edge, effective treatments that could give them more time to be there for special moments such as birthdays or seeing their children or grandchildren start school.
'Treatments, such as Enhertu, that patients in other countries, including Scotland, can access, giving them the chance to live longer.
'Women with secondary breast cancer tell us they feel their lives are being deprioritised by the changes to the system.
'We will not stand by and witness more drugs being rejected or not taken forward, when the devastating cost is thousands more people with secondary breast cancer across England, Wales and Northern Ireland having their lives cut short.'
Paula Van Santen, 50, was diagnosed with secondary breast cancer in July 2022, two months after her diagnosis of primary breast cancer.
The mother-of-three, from Banbury in Oxfordshire, said: 'Secondary breast cancer has changed the lives of both myself and my family beyond belief. Coming to terms with my diagnosis is the hardest part because I've had to grieve for the life I had, but also the life that I'm not going to have.
'If a new drug can give me another six months, if it gives me another year, it's worth it.
'It could allow me to see my daughter get to 21, see my children get married or meet grandchildren. Just to have a picture with a grandchild so they would know that I existed would be so precious. That's what this could give.'
Main symptoms of breast cancer in women
NHS
Ms Rowney called for 'change' and said Mr Streeting should scrap 'opportunity-cost neutral' restraints.
Opportunity cost neutrality in the Nice severity modifier aims to ensure the new system does not require more or less overall NHS funding than the old one.
According to the Breast Cancer Now report, this is 'at the root of the issues with the modifier'.
It added: 'It pits end-of-life cancer treatments against other severe conditions like cystic fibrosis in a way that's reductive and unfair to patients. And, ultimately, it creates barriers to the approval of drugs for advanced cancers.'
Ms Rowney said: 'The system for deciding whether drugs are approved for use on the NHS must change now.
'We're calling for immediate action from Wes Streeting, Secretary of State for Health and Social Care, to urgently scrap 'opportunity-cost neutral' restraints and for Nice to lower the bar for what it defines as 'a severe condition'. And we stand ready to work with them.'
Dr Samantha Roberts, chief executive of Nice, welcomed the report from Breast Cancer Now, saying: 'The independent analysis we commissioned recently showed the new severity weighting is working as intended and expected.
'It is able to be applied more widely – for example to treatments for cystic fibrosis, hepatitis D and Duchenne muscular dystrophy – and has contributed to an increase in positive decisions for cancer medicines and non-cancer medicines.
'And other breast cancer treatments have been recommended since we introduced the severity modifier – including for advanced breast cancer.
'We remain deeply disappointed that we were unable to recommend Enhertu for HER2-low advanced breast cancer. We know this was devastating to all those hoping for a different answer.
'It remains the only breast cancer treatment we have been unable to recommend in seven years.'
A Department of Health and Social Care spokesperson said the upcoming 10-year health plan will 'transform the NHS and improve care for those facing cancer'.
'This includes rolling out DIY screening kits for cervical cancer, more radiotherapy machines in every region and opening more Community Diagnostic Centres closer to where people live,' they added.
'We know how disappointing it is to many families that the manufacturers of Enhertu are unwilling to sell this life-extending treatment to the NHS at a fair and reasonable price. Our door remains open to supporting the introduction of medicines at a cost-effective price.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Telegraph
25 minutes ago
- Telegraph
Hancock: Discharging patients into care homes was ‘least-worst' Covid decision
Matt Hancock has insisted that discharging patients from hospitals to care homes in the early stages of the pandemic was 'the least-worst decision' at the time. The former health secretary admitted that forming a protective ring around care homes was 'impossible' as he doubled down on the policy, which was among the most controversial decisions of the pandemic. The Covid Inquiry previously heard there were more than 43,000 deaths involving the virus in care homes across the UK between March 2020 and July 2022. Alasdair Donaldson, a senior civil servant, was quoted earlier this week describing the toll as a ' generational slaughter within care homes '. On Wednesday, Mr Hancock acknowledged the discharge policy was an ' incredibly contentious issue ' but told the inquiry that 'nobody has yet provided me with an alternative that was available at the time that would have saved more lives'. When the pandemic hit in early 2020, hospital patients were rapidly discharged into care homes in a bid to free up beds and prevent the NHS from becoming overwhelmed. However, there was no policy in place requiring patients to be tested beforehand, or for asymptomatic patients to isolate, until mid-April. This was despite growing awareness of the risks of people without Covid symptoms being able to spread the virus. NHS 'insisted' on policy Mr Hancock, who resigned from the government in 2021 after admitting to breaking social distancing guidance while having an affair with a colleague, has now appeared at the inquiry seven times. Returning for a full-day session to face questions specifically about the care sector, Mr Hancock said the hospital discharge policy had been 'driven' by the then NHS chief executive Sir Simon Stevens, now Lord Stevens. Mr Hancock said: 'It was formally a government decision. It was signed off by the prime minister. It was really driven by Simon Stevens, the chief executive of the NHS, but it was widely discussed.'
ITV News
29 minutes ago
- ITV News
Princess of Wales opens up on cancer 'rollercoaster' on visit to Essex hospital
Experiencing cancer is 'life-changing' for both patients and their loved ones, the Princess of Wales said during a visit to a hospital in Essex. Kate said the recovery journey from cancer was a 'rollercoaster' as she discussed treatment and the importance of holistic cancer care with patients, volunteers and staff at Colchester Hospital's Wellbeing Centre on Wednesday. The princess, who revealed she had been diagnosed with cancer in March last year, praised the centre's 'holistic' approach to the support it offers patients, relatives and carers which includes counselling and dietary advice. While chatting to a group of the centre's users, volunteers and staff, the princess said: 'It's life-changing for anyone, through first diagnosis or post-treatment and things like that, it is life-changing experience both for the individual patient but also for the families as well. "Actually it sometimes goes unrecognised. You don't necessarily, particularly when it's the first time, you don't appreciate how much impact it is going to have. 'You have to find your new normal and that takes time. 'Someone described the sort of healing, recovery journey to me as being like a sort of zig-zag. 'It's a rollercoaster, it's not one smooth plain, which you expect it to be, but the reality is it's not, you go through hard times and to have a place like this, to have the support network, whether it's through creativity and singing or gardening, whatever it might be, is so valuable and it's great that this community has it. 'It would be great if lots of communities had this kind of support.' She added: 'There is this whole phase when you finish your treatment that you, yourself, everybody [thinks], 'Right you've finished your time, go, you're better', and that's not the case at all.' After visiting the centre, the princess braved the drizzly weather to plant several coral-pink Catherine's Rose plants in the hospital's Royal Horticultural Society (RHS) Wellbeing Garden. The RHS named the flower after Kate to raise awareness of the role that spending time outdoors plays in supporting people's mental, physical and spiritual wellbeing. Foregoing gardening gloves which were offered to her, she knelt down to plant the roses using her bare hands and a trowel to pat down the soil alongside Adam Frost, the award-winning garden designer who led the design of the space. Opened in July last year, the wellbeing garden at the hospital offers a relaxing and restorative space for NHS staff, patients and visitors.
The Independent
29 minutes ago
- The Independent
Kate Middleton reveals ‘life-changing' cancer journey has been a ‘rollercoaster'
The Princess of Wales openly discussed her 'life changing' cancer journey and 'rollercoaster' recovery on a visit to an Essex hospital. Speaking at Colchester Hospital, Kate Middleton revealed the toll cancer takes on family and friends. 'It is a life-changing experience both for the individual patient but also for the families as well and actually it sometimes goes unrecognised, you don't necessarily, particularly when it's the first time, you don't appreciate how much impact it is going to have,' the princess told a group of users, volunteers and staff at the Cancer Wellbeing Centre. The princess was diagnosed with an unknown form of cancer in March last year, in the same year as the King was also diagnosed with cancer. On her visit to the hospital, she praised the centre's 'holistic' approach to the support it offers patients, relatives and carers, which includes counselling and dietary advice. 'There is this whole phase when you finish your treatment that you, yourself, everybody expects you, right you've finished your time, go, you're better, and that's not the case at all,' she added. 'You have to find your new normal and that takes time.' After visiting the centre, the princess planted several coral-pink Catherine's Rose plants in the hospital's Royal Horticultural Society (RHS) wellbeing garden, which offers a restorative space for staff, patients and visitors.
